A Phase III open-label, single-arm, multi-center study to assess the safety and efficacy of brigimadlin (BI907828) treatment in patients with treatment-na??ve or pre-treated advanced dedifferentiated liposarcoma

Project: Research project

Project Details

Description

A Phase III open-label, single-arm, multi-center study to assess the safety and efficacy of brigimadlin (BI 907828) treatment in patients with treatment-na??ve or pre-treated advanced dedifferentiated liposarcoma
StatusFinished
Effective start/end date8/21/2411/26/24

Funding

  • BOEHRINGER INGELHEIM VETMEDICA, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.